(S)-4’-Hydroxy warfarin
CAS : 68407-05-6
Ref. 3D-TCA40705
| 1mg | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté |
Informations sur le produit
Nom :
(S)-4’-Hydroxy warfarin
Synonymes :
- 2H-1-Benzopyran-2-one, 4-hydroxy-3-[1-(4-hydroxyphenyl)-3-oxobutyl]-, (S)-
- 4-Hydroxy-3-[(1S)-1-(4-hydroxyphenyl)-3-oxobutyl]-2H-1-benzopyran-2-one
- (S)-4′-Hydroxywarfarin
- 4′-Hydroxy-S-warfarin
- 2H-1-Benzopyran-2-one, 4-hydroxy-3-[(1S)-1-(4-hydroxyphenyl)-3-oxobutyl]-
Description :
Warfarin is a coumarin-type anticoagulant that inhibits the synthesis of vitamin K-dependent clotting factors, which are necessary for blood coagulation. It is also used as an anticancer agent in animals and humans. Warfarin inhibits the activity of cytochrome P450 (CYP) enzymes, including CYP2C9, CYP2C19, and CYP3A4. This inhibition may lead to drug interactions with other drugs metabolized by these enzymes. Warfarin has been shown to have anticancer effects in both cell culture and animal models. The anticancer effect of warfarin is due to its ability to inhibit the growth of cancer cells by interfering with the synthesis of DNA and RNA.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
324.3 g/mol
Formule :
C19H16O5
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
